Amelia C.pptx

Embed Size (px)

Citation preview

  • 7/30/2019 Amelia C.pptx

    1/13

    CORRELATION BETWEEN NSAIDs

    AND PEPTIC ULCER IN ELDERLY

    Amelia Christiana

    030.08.021

  • 7/30/2019 Amelia C.pptx

    2/13

    INTRODUCTION

  • 7/30/2019 Amelia C.pptx

    3/13

    PEPTIC ULCER

  • 7/30/2019 Amelia C.pptx

    4/13

    GASTRODUODENAL MUCOSAL

    DEFENSE

  • 7/30/2019 Amelia C.pptx

    5/13

    SYNTHESIS PROSTAGLANDINE

  • 7/30/2019 Amelia C.pptx

    6/13

    WHY NSAID MOST USE IN ELDERLY?

    TAKING CONTINOUSLY

  • 7/30/2019 Amelia C.pptx

    7/13

    SOME EXAMPLE OF NSAIDs

    indomethacin ketorolac ketoprofen nabumetone

    naproxen oxaprozin sulindac tolmetin

    piroxicam ibuprofen Aspirin etodolac,

    diflunisal diclofenac celecoxib

    http://www.medicinenet.com/script/main/art.asp?articlekey=766http://www.medicinenet.com/script/main/art.asp?articlekey=44619http://www.medicinenet.com/script/main/art.asp?articlekey=799http://www.medicinenet.com/script/main/art.asp?articlekey=822http://www.medicinenet.com/script/main/art.asp?articlekey=795http://www.medicinenet.com/script/main/art.asp?articlekey=734http://www.medicinenet.com/script/main/art.asp?articlekey=721http://www.medicinenet.com/script/main/art.asp?articlekey=846http://www.medicinenet.com/script/main/art.asp?articlekey=750http://www.medicinenet.com/script/main/art.asp?articlekey=792http://www.medicinenet.com/script/main/art.asp?articlekey=697http://www.medicinenet.com/script/main/art.asp?articlekey=778http://www.medicinenet.com/script/main/art.asp?articlekey=743http://www.medicinenet.com/script/main/art.asp?articlekey=859http://www.medicinenet.com/script/main/art.asp?articlekey=8257http://www.medicinenet.com/script/main/art.asp?articlekey=8257http://www.medicinenet.com/script/main/art.asp?articlekey=859http://www.medicinenet.com/script/main/art.asp?articlekey=743http://www.medicinenet.com/script/main/art.asp?articlekey=778http://www.medicinenet.com/script/main/art.asp?articlekey=697http://www.medicinenet.com/script/main/art.asp?articlekey=792http://www.medicinenet.com/script/main/art.asp?articlekey=750http://www.medicinenet.com/script/main/art.asp?articlekey=846http://www.medicinenet.com/script/main/art.asp?articlekey=721http://www.medicinenet.com/script/main/art.asp?articlekey=734http://www.medicinenet.com/script/main/art.asp?articlekey=795http://www.medicinenet.com/script/main/art.asp?articlekey=822http://www.medicinenet.com/script/main/art.asp?articlekey=799http://www.medicinenet.com/script/main/art.asp?articlekey=44619http://www.medicinenet.com/script/main/art.asp?articlekey=766
  • 7/30/2019 Amelia C.pptx

    8/13

    RISK FACTOR NSAIDs ULCER

    AGE

    DURATION AND DOSE THERAPY

    COTHERAPY WITH OTHER DRUG

    STRESS

  • 7/30/2019 Amelia C.pptx

    9/13

  • 7/30/2019 Amelia C.pptx

    10/13

  • 7/30/2019 Amelia C.pptx

    11/13

    REFERENCES

    Soll AH, Graham DY. Textbook of Gastroenterology: Peptic Ucer.West Sussex : Willey Blackwell Publishing; 2009. p. 936-1004.

    Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL,Loscalzo J. Harrison's principles of internal medicine (17th ed.). NewYork: McGraw-Hill Medical Publishing Division; 2008.p. 1645-1660.

    Takezono Y, Joh T, Oshima T, Suzuki H, Seno K, Yokoyama Y,Alexander JS, Itoh M. Role of prostaglandins in maintaining gastricmucus-cell permeability against acid exposure. J Lab Clin Med.2004. 143: 5258.

    Tanaka A, Araki H, Komoike Y, Hase S, Takeuchi K. Inhibition of bothCOX-1 and COX-2 is required for development of gastric damage inresponse to nonsteroidal anti-inflammatory drugs. J Physiol. 2001.95: 2127.

    Laine L. Approaches to non-steroidal anti-inflammatory drug use inthe high-risk patient. Gastroenterology. 2001. 120: 594596.

  • 7/30/2019 Amelia C.pptx

    12/13

    REFERENCES

    Baumgartner HK, Starodub OT, Joehl JS, Tackett L, Montrose MH. Cyclooxygenase 1is required for pH control at the mouse gastric surface. Gut. 2004. 53: 17511757.

    Jaworski T, Sarosiek I, Sostarich S, Roeser K, Connor M, Brotze S, Wallner G,Sarosiek J. Restorative impact of rabeprazole on gastric mucus and mucinproduction impairment during naproxen administration: its potential clinicalsignificance. Dig Dis. 2005. Sci 50: 357365.

    Darling RL, Romero JJ, Dial EJ, Akunda JK, Langenbach R, Lichtenberger LM. Theeffects of aspirin on gastric mucosal integrity, surface hydrophobicity,prostaglandin metabolism in cyclooxygenase knockout mice.Gastroenterology.2004. 127: 94104.

    Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B.Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs:results of a double-blind, randomized, multicenter, active- and placebo-controlled

    study of misoprostol vs lansoprazole. Arch Intern Med. 2002. 162: 169

    175. Ma L, Elliott SN, Cirino G, Buret A, Ignarro LJ, Wallace JL. Platelets modulate gastric

    ulcer healing: role of endostatin and vascular endothelial growth factor release.Proc Natl Acad Sci USA. 2001. 98: 64706475

  • 7/30/2019 Amelia C.pptx

    13/13